Show simple item record

dc.contributor.authorFallon, Padraic
dc.contributor.authorKnolle, Martin D.
dc.contributor.authorChin, Shau Bing
dc.contributor.authorRana, Batika M.J.
dc.contributor.authorEnglezakis, Alexandros
dc.contributor.authorNakagawa, Rinako
dc.contributor.authorGit, Anna
dc.contributor.authorMcKenzie, Andrew N.J.
dc.date.accessioned2019-10-29T14:59:42Z
dc.date.available2019-10-29T14:59:42Z
dc.date.issued2018
dc.date.submitted2018en
dc.identifier.citationKnolle, M.D., Chin, S.B., Rana, B.M.J., Englezakis, A., Nakagawa, R., Fallon, P.G., Git, A. & McKenzie, A.N.J., MicroRNA-155 Protects Group 2 Innate Lymphoid Cells From Apoptosis to Promote Type-2 Immunity., Frontiers Immunology, 9, 2018, 2232en
dc.identifier.otherY
dc.descriptionPUBLISHEDen
dc.description.abstractGroup-2 innate lymphoid cells (ILC2) play critical roles in the initiation and maintenance of type-2 immune responses, predominantly through their production of the type-2 cytokines IL-5, IL-9, and IL-13. ILC2 are essential for the efficient elimination of helminth parasites, but also contribute to the detrimental type-2 immune responses that underlie diseases such as asthma and allergy. While several transcription factors have been identified that regulate the development and function of ILC2, less is known about the post-transcriptional mechanisms that regulate these processes. We identified micro-RNAs (miRNAs) that are co-ordinately regulated in ILC2 from mice exposed to two different stimuli, namely IL-33 “alarmin” administration or Nippostrongylus brasiliensis parasitic worm infection. miR-155 is upregulated in ILC2 in response to both stimuli and miR-155−/− mice had impaired IL-33-driven ILC2 responses. Using mixed bone marrow chimeras, we demonstrate that this deficit is intrinsic to ILC2 and that miR-155 protects ILC2 from apoptosis, while having little impact on ILC2 proliferation or cytokine production. These data reveal a subset of miRNAs that are regulated upon ILC2 activation and establish a specific role for miR-155 in regulating ILC2 survival following activation.en
dc.format.extent2232en
dc.language.isoenen
dc.relation.ispartofseriesFrontiers Immunology;
dc.relation.ispartofseries9;
dc.rightsYen
dc.subjectmiR-155en
dc.subjectILC2en
dc.subjectApoptosisen
dc.subjectIL-33en
dc.subjectType-2 immunityen
dc.titleMicroRNA-155 Protects Group 2 Innate Lymphoid Cells From Apoptosis to Promote Type-2 Immunity.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/pfallon
dc.identifier.rssinternalid197863
dc.identifier.doihttps://dx.doi.org/10.3389%2Ffimmu.2018.02232
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeImmunology, Inflammation & Infectionen
dc.identifier.orcid_id0000-0002-8401-7293
dc.status.accessibleNen
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02232/full
dc.identifier.urihttp://hdl.handle.net/2262/89933


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record